Literature DB >> 12163784

Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.

Satoshi Gando1, Takashi Kameue, Yuji Morimoto, Naoyuki Matsuda, Mineji Hayakawa, Osamu Kemmotsu.   

Abstract

OBJECTIVE: To determine the precise relationship among tissue factor, tissue factor pathway inhibitor (TFPI), and neutrophil elastase in sepsis, as well as to test the hypothesis that low TFPI concentrations are not sufficient to prevent tissue factor-dependent intravascular coagulation, leading to multiple organ dysfunction syndrome and death.
DESIGN: Prospective, cohort study.
SETTING: General intensive care unit of tertiary care emergency department. PATIENTS: Thirty-one consecutive patients with sepsis, classified as 15 survivors and 16 nonsurvivors. Ten normal, healthy volunteers served as controls.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Tissue factor antigen concentration (tissue factor), TFPI, neutrophil elastase, and global variables of coagulation and fibrinolysis were measured on the day of diagnosis of sepsis, severe sepsis, and septic shock and days on 1-4 after diagnosis. The number of systemic inflammatory response syndrome criteria that patients met and the disseminated intravascular coagulation score were determined simultaneously. The results of these measurements were compared between the survivors and the nonsurvivors. In the nonsurvivors, significantly higher concentrations of tissue factor and neutrophil elastase were found compared with the survivors and control subjects. However, the TFPI values showed no difference between the two groups. No correlation was found between the peak concentrations of tissue factor and TFPI. Disseminated intravascular coagulation scores and numbers of the SIRS criteria met by the survivors significantly decreased from day 0 to day 4, but those of the nonsurvivors did not improve during the study period. The nonsurvivors showed thrombocytopenia and higher numbers of dysfunctioning organs than did the survivors.
CONCLUSIONS: We systematically elucidated the relationship between tissue factor and TFPI in patients with sepsis, severe sepsis, and septic shock. Activation of tissue factor-dependent coagulation pathway not adequately balanced by TFPI has important roles in sustaining DIC and systemic inflammatory response syndrome, and it contributes to multiple organ dysfunction syndrome and death. High concentrations of neutrophil elastase released from activated neutrophils may explain, in part, the imbalance of tissue factor and TFPI in sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163784     DOI: 10.1097/00003246-200208000-00009

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

1.  Markers of inflammation and coagulation may be modulated by enteral feeding strategy.

Authors:  Julie A Bastarache; Lorraine B Ware; Timothy D Girard; Arthur P Wheeler; Todd W Rice
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-02-07       Impact factor: 4.016

2.  Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis.

Authors:  Takeo Yasuda; Takashi Ueda; Keiko Kamei; Wataru Shinzaki; Hidehiro Sawa; Makoto Shinzeki; Yonson Ku; Yoshifumi Takeyama
Journal:  J Gastroenterol       Date:  2009-06-30       Impact factor: 7.527

Review 3.  A brief overview of acute respiratory distress syndrome.

Authors:  Robert M Hardaway
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

4.  Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.

Authors:  C Lupu; O Herlea; H Tang; R H Lijnen; F Lupu
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

5.  Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.

Authors:  Haiwang Tang; Lacramioara Ivanciu; Narcis Popescu; Glenn Peer; Erik Hack; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

6.  Multiple organ dysfunction syndrome.

Authors:  A L Parke; P T Liu; D V Parke
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

7.  Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Jinjin Hao; Weiming Li; Ping Zou; Quan Li; Linghui Xia; Yong You
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

8.  Tissue factor and tissue factor pathway inhibitor in chronically inflamed gallbladder mucosa.

Authors:  Jacek Liczko; Tomasz Stawski; Małgorzata Zaba; Józef Kurek; Daniel Sabat; Grzegorz Wyrobiec; Dorota Domal-Kwiatkowska; Damian Dudek; Marek Kucharzewski; Krzysztof Helewski
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

9.  Severe community acquired pneumonia update: mortality, mechanisms and medical intervention.

Authors:  Pierre-Francois Laterre
Journal:  Crit Care       Date:  2008-11-26       Impact factor: 9.097

10.  The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation.

Authors:  Vincent Peigne; Elie Azoulay; Isaline Coquet; Eric Mariotte; Michael Darmon; Paulette Legendre; Nadir Adoui; Anne Marfaing-Koka; Martine Wolf; Benoit Schlemmer; Agnès Veyradier
Journal:  Crit Care       Date:  2013-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.